Entyvio 300 mg intravenous solution


Get it to United States within 10 working days with standard delivery.

Fast delivery to United States

Easy Returns & Exchanges

Ask About This Product

Condition : New


From UAE

To United States

in 5-10 days


How it Works

Entyvio (vedolizumab) is a biologic medication used to treat certain autoimmune conditions of the gastrointestinal tract. Vedolizumab is an integrin receptor antagonist that works by specifically binding to the ?4?7 integrin, a protein on the surface of specific white blood cells (lymphocytes). By binding to this integrin, vedolizumab inhibits the interaction between the ?4?7 integrin and the mucosal addressin cell adhesion molecule-1 (MAdCAM-1). This interaction is crucial for the movement (trafficking) of white blood cells into the inflamed gastrointestinal tissue. By preventing this interaction, vedolizumab reduces inflammation and symptoms in conditions like ulcerative colitis and Crohn?s disease.

Side Effects

  • Nasopharyngitis
  • Headache
  • Arthralgia (joint pain)
  • Nausea
  • Fever
  • Fatigue
  • Upper respiratory tract infection
  • Bronchitis
  • Urinary tract infection
  • Back pain
  • Rash
  • Pruritus (itching)


  • Moderate to severe ulcerative colitis in adults
  • Moderate to severe Crohn’s disease in adults


  • Known hypersensitivity to vedolizumab or any of its components
  • Active severe infections (e.g., tuberculosis)
  • Patients with a history of progressive multifocal leukoencephalopathy (PML)
  • Severe liver impairment (use with caution)
  • Pregnancy and lactation (use with caution and only if clearly needed)

Price Comparison in Different Countries

Country Price (USD) Website
United States $5,800 GoodRx
Canada $4,500 PharmacyChecker
United Kingdom ?3,000 NHS
Australia AUD 7,200 PBS
India ?400,000 Medindia

Top 5 Global Brands

  1. Entyvio (Takeda Pharmaceuticals)
  2. Humira (AbbVie)
  3. Remicade (Janssen Biotech)
  4. Stelara (Janssen Biotech)
  5. Simponi (Janssen Biotech)
Shopping Cart